National Comprehensive Cancer Network

About NCCN

NCCN International Programs – Latin America

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

The National Comprehensive Cancer Network® (NCCN®) aims to define and improve high-quality, high-value cancer care in Latin America.

In 2015, NCCN participated in two of the most renowned oncology congresses in Brazil. In September, Joan S. McClure, MS, Senior Vice President of Clinical Information and Publications, NCCN, traveled to Brasilia, Brazil to participate in the 20th Brazilian Oncology Congress, and Robert W. Carlson, MD, Chief Executive Officer, NCCN, traveled to Iguazu Falls, Brazil to present at the Brazilian Oncology Society Congress in October. Each congress brought together thousands of national and international oncology professionals covering various areas of advancement in the treatment and management of cancer in Brazil.

NCCN has a large active presence in Latin America with more than 60,000 registered oncology professionals and more than 290,000 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) downloaded in 2015.

>The graph above represents the top countries of registered users in Latin America<

Translations and Adaptations of the NCCN Guidelines® for Latin America

In 2014, NCCN entered into a three-year collaboration with LACOG (Latin American Cooperative Oncology Group) to update and develop the NCCN Guidelines® for Prostate Cancer Latin American Edition annually. In 2016, NCCN faculty plans to meet with a multidisciplinary group of physicians from LACOG to accomplish the third update of the NCCN Guidelines for Prostate Cancer Latin American Edition. Attendees will consider regional adaptations of the NCCN Guidelines for Prostate Cancer, which are necessary for effective utilization of the NCCN Guidelines in Latin America. LACOG representatives will include physicians from Argentina, Brazil, Chile, Mexico, and Peru. Moreover, the 2016 Versions of the Latin America Editions of the NCCN Guidelines for Prostate Cancer will be available by the end of 2016.

NCCN began collaborating with LACOG in 2010, resulting in the 2011 publication of NCCN Guidelines for Breast Cancer and Non-Small Cell Lung Cancer Latin American Editions, which were translated into Portuguese and Spanish. LACOG is a non-profit organization founded in 2008 by a group of Latin American medical oncologists interested in the development of academic clinical research. LACOG is the first multinational cooperative group in Latin America exclusively dedicated to clinical and translational research in cancer.

In addition to LACOG, NCCN works in collaboration with third party organizations across the globe to present the NCCN Guidelines and the translations and adaptations of the NCCN Guidelines to international audiences of clinicians and other medical professionals. The Adaptations of the NCCN Guidelines are country-specific clinical practice guidelines in English or the local language(s). They include adaptations accounting for metabolic differences in populations, accessibility of technology, and regulatory status of health care technologies used in cancer management in the specified country.

The Adaptations of the NCCN Guidelines are developed by the host country's oncology thought leaders in conjunction with NCCN Guidelines Panel Members. Modified NCCN Guidelines are developed to aid clinicians in determining appropriate and effective avenues of care in the specified country.

To view the entire library of 17 translations and eight adaptations of NCCN Guidelines® for Latin America, visit

If you would like to learn more about regional adaptations of the NCCN Guidelines or other international programming opportunities, please contact Jorge Bacigalupo,